secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALX ONCOLOGY HOLDINGS INC (ALXO)
CIK:        0001810182
Form:       8-K
Filed at:   2021-08-27T23:59:59+00:00
Accession:  0001564590-21-046136
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Graham Walmsley resigns from ALX Oncology board effective Aug 26, 2021
-------------------------------------------------------------------------------

- Graham Walmsley resigned due to professional responsibilities at Logos Global Management, not due to any disagreement.
- Board size reduced from seven to six directors.
- Jason Lettmann appointed to the Audit Committee following the resignation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810182/000156459021046136/0001564590-21-046136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810182/000156459021046136/alxo-8k_20210826.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-046136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer